Coverage
-
October 02, 2015
Bayer Corp. did not advertise its Phillips' Colon Health probiotics as a disease-curing drug and had the proper research to substantiate advertised claims regarding its effectiveness, a New Jersey federal judge said in an opinion unsealed Thursday, nixing a complaint brought by the Federal Trade Commission.
4 other articles on this case.
View all »